Abstract The International Working Group on the Diabetic Foot (IWGDF) has published
evidence‐based guidelines on the prevention and management of diabetic foot disease …

Background There are uncertainties regarding the diagnostic criteria, optimal treatment
methods, interventions, monitoring and determination of remission of Charcot neuro …

Aims Contralateral temperature difference (CTD) is a frequently used marker of healing in
Charcot neuro‐osteoarthropathy (CN). We aimed to determine whether there is a consistent …

Charcot neuro-osteoarthropathy (CN) has been described more than two and a half
centuries ago. 1 Until today, the pathophysiology is not fully understood. 2 Presence of …

Diabetic foot is a common complication affecting more than one-fifth of patients with
diabetes. If not treated in time, it may lead to diabetic foot ulcers or Charcot arthropathy. For …

Diabetes-related foot disease (DFD), defined as ulceration, infection or destruction of tissues
of the foot in a person with current or previously diagnosed diabetes mellitus, is associated …

Charcot can be a difficult clinical entity to diagnose in the acute phase, and clinicians should
have a high clinical suspicion in neuropathic patients who present with erythema, edema …

OBJECTIVE Charcot foot (CF) requires prolonged offloading of the affected foot to decrease
the risk of deformity. The earliest phase in active CF (stage 0) is characterized by …

Background: If unrecognized, Charcot neuro-osteoarthropathy (CNO) can be a devastating
complication of diabetes. Methods: The aim of this retrospective study was to evaluate the …

Aim To evaluate the real-life diagnosis and therapeutic means of Charcot
Neuroosteoarthropathy (CN) in French-Belgian diabetic foot expert centers. Methods We …